SEC Info - Noble Consolidated Industries Corp

SEC Info℠

Home

Help

Please Sign In

Noble Consolidated Industries Corp – ‘S-8 POS’ on 10/29/01

On: Monday, 10/29/01 · Effective: 10/29/01 · Accession #: 1104194-1-500019 · File #: 333-72382

  As Of                Filer                Filing    For·On·As Docs:Size

10/29/01  Noble Consolidated Inds Corp      S-8 POS    10/29/01    1:27K

Post-Effective Amendment to an S-8 — Form S-8
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-8 POS     Amended S-8                                           13     53K

Document Table of Contents

Page	(sequential)	\|	(alphabetic)	Top
			Alternative Formats (Word, et al.) Description of Securities Indemnification Information with Respect to the Company Interests of Named Experts and Counsel Undertakings
1	1st Page - Filing Submission
6	Item 3. Information with Respect to the Company
7	Item 4. Description of Securities
"	Item 5. Interests of Named Experts and Counsel
8	Item 6. Indemnification
"	Item 9. Undertakings

S-8 POS 1st Page of 13 TOC ↑Top Previous Next ↓Bottom Just 1st
 
UNITED STATES   
SECURITIES AND EXCHANGE COMMISSION    
Washington D.C., 20549    

Form S-8    
REGISTRATION STATEMENT    
Under   
The Securities Act of 1933    

Commission file number 000-25523    

EBAIT, INC.       

(Exact name of registrant as specified in charter)    

California                                     33-0843633             
State of other jurisdiction of              I.R.S. Employer           
incorporation or organization               Identification Number     

2279 Segundo Ct. Suite 4                                              
Pleasonton, CA                                94588                   
Address of Principal Executive Office      Zip Code                   

Retainer Stock Plan for Non Employee Directors and Consultants      
Full Title of the Plan      

925 462 6280      
Registrants Telephone Number, Including Area Code       

Brian Dvorak, Esq.          
3360 W. Sahara Suite 230    
Las Vegas, NV 89102         
Name and Address of Agent for Service             

                                                                [Download Table]
Title of Securities to   Amount to    Proposed    Proposed      Amount of  
be registered                be       maximum      maximum     registration
                         registered   Offering    aggregate        fee     
                                     price per    offering                 
                                      share 2      price                   
                                                                           
Common Stock (1)          300,000       $1.30      $390,000         $270   

1    Represents up to 300,000 shares of common stock to be offered for          
resale by the persons indicated in the prospectus included as part of this      
Registration Statement, in addition to the additional shares offered herein.    

2    Calculated in accordance with Rule 457 c using the average of the low      
and high prices for the common stock on October 9, 2001.                        

S-8 POS 2nd Page of 13 TOC 1st Previous Next ↓Bottom Just 2nd
PROSPECTUS                   The date of this Prospectus is October 9, 2001     

 EBAIT, INC.

Up to 300,000 Shares of Common Stock      
Received by Directors, Officers, Consultants and Employees    

Selling  shareholders of EBAIT, INC. Company will offer  their  shares          
through  the  over the counter market or through  NASDAQ,  if  the  Companys    
common  stock is then included for quotation on NASDAQ. Selling shareholders,   
if  control persons, are required to sell their shares in accordance with the   
volume limitations of Rule 144 under the Securities Act of 1933, which limits   
sales  by each selling shareholder in any one quarter period to the greater  of 
1%  of  the  total outstanding common stock or approximately 200,000  shares    
after the issuance of the shares herein or the average weekly trading volume    
of  the  Companys  common stock during the four calendar  weeks  immediately    
preceding  such  sale.  It  is expected that brokers  and  dealers  effecting   
transactions  will  be paid the normal and customary commissions  for  market   
transactions; however the Shares may be sold in a private transaction.          

The  Companys Common Stock is currently quoted on the National  Associations    
of  Securities  Dealers  NASD Over the Counter Bulletin  Board  OTCBB           
under  the  symbol EBAI.  On October 9, 2001, the lowest bid  price of the      
common  stock was $1.30 per share, the closing low and high prices of  shares   
of  Common Stock of the Company were $1.30 and $1.30, respectively.  However,   
the  Company considers its Common Stock to be thinly traded and, as a result,   
any  reported  sales prices may not be a true market based valuation of the     
Common Stock.                                                                   

THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND    
EXCHANGE COMMISSION, NOR HAS THE COMMISSION PASSED ON THE ACCURACY OR THE       
ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL   
OFFENSE.                                                                        

No person has been authorized by the Company to give any information or to      
make  any representation other than as contained in this Prospectus and, if     
given or made, such information or representation must not be relied upon  as   
having  been  authorized  by  the  Company.  Neither the delivery  of  this     
Prospectus  nor  any distribution of the shares of the Common Stock issuable    
under  the  terms  of  the  Plan shall, under any circumstances, create any     
implication that there has been no change in the affairs of the Company since   
the date hereof.                                                                

This Prospectus does not constitute an offer to sell securities in any state    
to any person to whom it is unlawful to make such offer in such state.          
The securities offered hereby involve a high degree of risk. See Risk           
Factors.                                                                        

S-8 POS 3rd Page of 13 TOC 1st Previous Next ↓Bottom Just 3rd
SUMMARY OF PROSPECTUS   

Item 1.                                                                         

The Company                                                                     

This  prospectus  accompanies reoffers by consultants and  employees  of  the   
Company  of  shares of common stock received through the Companys Consultant    
and   Employee  Compensation  Plan.  The  Company,  pursuant   to   the   S8    
Registration, dated this same date, has registered 300,000 of the Companys      
common  stock,  which  shares  are to be issued  pursuant  to  the  Company's   
Consultant  and  Employee  Stock Compensation Plan. The  Companys  principal    
offices  are  located  at 3360 W. Sahara Suite 230, Las Vegas, NV 89102,        
telephone number 702 732 2253.                                                  

 This form S8 contains forward-looking statements within the meaning  of
the federal securities laws. These forward-looking statements are necessarily   
based  on  certain  assumptions  and are subject  to  significant  risks  and   
uncertainties.  These  forward looking statements are based  on  managements    
expectations  as of the date hereof, and the Company does not  undertake  any   
responsibility to update any of these statements in the future. Actual future   
performance  and results could differ from that contained in or suggested  by   
these  forward looking statements as a result of factors set  forth  in  this   
Form  S8  including those sections hereof incorporated  by  reference  from     
other filings with the Securities and Exchange Commission                       

RISK FACTORS                

The  purchase of the securities offered hereby is subject to risk.  Investors   
should evaluate these risk factors carefully.                                   

Need  for  Additional Financing.  The Company has been financed through  the    
sale  of  its  common  stock.  In order to succeed the  Company  may  require   
additional  capital for working capital and for marketing. There  can  be  no   
assurance that such financing will be available, when required, on acceptable   
terms.                                                                          

Markets   Uncertain.  Despite  the  business  experience  of  the   officers,   
directors,  and  principal  shareholders of the Company,  and  the  Companys    
products  there  can be no assurance that markets for the Companys  products    
will  continue  to  be  sizable  enough to  permit  the  Company  to  operate   
profitably.                                                                     

Reliance on Management. All decisions with respect to the management  of  the   
Company will be made exclusively by its officers and directors.   To a  large   
extent,  the  success  of the Company will depend upon  the  quality  of  the   
management provided by its officers and directors.                              

Dependence  upon  Key Personnel. The success of the Company will  be  largely   
dependent  on the personal efforts of key employees, officers, and directors,   
who  are responsible for the development of the business of the Company.   If   
any  of  the  key employees, officers or directors should, for  whatever  the   
reason, cease to serve the Company, the Company may find it difficult to find   
replacements  within a short time frame, and thus, the Company's  ability  to   
meet its goals could be adversely affected.                                     

Company Capitalization. To the extent that the funding may be insufficient to   
meet  expenses,  the  Company may be required to  obtain  the  funds  through   
additional  borrowings by raising funds through selling equity  interests  in   
the  Company.   Management believes that operating profits can be  generated,   
but  both  the  production  of  intellectual properties  and  any  return  to   
Shareholders may take considerably longer than anticipated.                     

S-8 POS 4th Page of 13 TOC 1st Previous Next ↓Bottom Just 4th
PART I    

Item 2.                                                                         

General                                                                         

EBait, Inc. EBAIT is a California corporation whose purpose is to develop and   
distribute innovative products.  It is a fast growing, world-wide food and      
trading company, with distribution and access to resources and products around  
the world. EBAITs core product line is soy and dairy based powdered milk        
products. Currently EBAITs foremost product is Pride & Joy, an infant formula.  
Other products that are in various stages of development, patenting, and        
distribution are discussed in The Product portion of this Summary.              

EBAITs core product line is soy and dairy based powdered milk products. EBAIT   
management believes that customers want our products and will pay for the       
convenience and higher digestibility of our nutritionally balanced formulas and 
all natural substitute milk products.                                           

The  Companys  principal  executive offices  are  located  at  3960 Howard      
Hughes Parkway, Suite 500, Las Vegas, NV 89109, telephone 702 990 3623.         

                                                        [Enlarge/Download Table]
Management                                                                                                                
                                                                                                                          
Rendal Williams                 CEO                                                                                       
Darrel Holmes                   President                                                                                 
Don Chairez                     Secretary Treasurer                                                                       

R. Williams CEO                                                                                                           

Mr. Williams is an experienced senior management professional in the food and                                             
beverage industry.  He has over 18 years experience in marketing and sales and                                            
executive management positions with proven performance. To each company, he has                                           
brought significant financial returns and advanced to top management positions.                                           

In addition, Mr. Williams has spent much of the last two years in Central                                                 
America. He has been working to develop products that are uniquely suited for                                             
the developing countries, along with setting up a pilot plant in Guatemala to                                             
produce these products.                                                                                                   

Mr. Williams current primary effort is to assemble the management team capable                                            
of implementing the plans, goals and aspirations of EBAIT.  EBAIT is a startup                                            
company that has set aggressive goals and, as CEO, Mr. Williams is building a                                             
team that shares his vision and will work together to achieve them.  His                                                  
management style promotes vigorous interaction among team members, and                                                    
facilitates problem solving. He is working to coordinates the varied activities                                           
of EBAIT and promoting a fast paced organization capable of responding quickly                                            
to market opportunities.                                                                                                  

Mr. Williams will evaluate business opportunities for EBAIT and determine the                                             
best course for the company.  He is currently evaluating new products, joint                                              
ventures, acquisitions and other collaborations that make sense for the company                                           
and move the company quickly toward its goals.                                                                            

In addition to strong senior management qualifications, Mr. Williams brings to                                            
BFI demonstrated experience in business planning, and new products ideas that                                             
will provide every opportunity for BFI to meet its aggressive goals and make                                              
the company a success.                                                                                                    

D. Holmes President                                                                                                       

Darrel L. Holmes is an accomplished executive with over 22 years experience in                                            
the medical diagnostics, biotech, environmental, and food and beverage                                                    
industries.  He has extensive experience in plant operations, product                                                     
development, regulatory interface primarily the FDA which also regulates                                                  
EBAIT and senior management.  Mr. Holmes has managed technical manufacturing                                              
sites with over 100 people under his supervision and operations producing over                                            
80 million dollars in annual sales.  Mr. Holmes has a degree in Biology with                                              
numerous post graduate classes, seminars and certifications.  He is capable in                                            
technical as well as regulatory and management areas.  He is a hand on manager                                            
who continually seeks to make improvements, build teamwork within an                                                      
organization and produce high quality products, on schedule, for an acceptable                                            
profit.                                                                                                                   

Mr. Holmes is an excellent problem solver whose innovative and resourceful                                                
management style make him well suited to lead and motivate employees and manage                                           
a company.                                                                                                                

Mr. Holmes has held executive positions with companies all involved in                                                    
scientific endeavors.  He is a proven technical manager and has expanded the                                              
sales and production efficiencies everywhere he has worked.  As part of his                                               
technical capabilities, he has been directly responsible for operating and                                                
managing all technical operations for diagnostics and biotech companies and he                                            
will perform similar functions as Vice President of Operations and President                                              
for BFI. He has been responsible for aseptic and sterile reagent manufacturing,                                           
filling, labeling, packaging and distribution.                                                                            

In past employment, Mr. Holmes has operated a large bottled water company,                                                
setting up a cell biology division for a leading biotech company, and managing                                            
an established medical diagnostics company with excellent success.  He                                                    
understands inventory management and computer controls. He works closely with                                             
managers and supervisors to assure that adequate systems are in place to                                                  
monitor control and improve business and technical departments to assure the                                              
operations continuity, profitability and success.                                                                         

Statement of Corporate Positions                                                                                          
Mothers Milk:                                                                                                             

EBAIT acknowledges that mothers natural milk is the best possible source of                                               
nutrition for infants up to one year old.  The products sold are not intended                                             
to undermine natural breast-feeding.  EBAITs products are intended provide                                                
infant nourishment if the mother is unable or chooses not to provide breast                                               
milk.  EBAIT will work with industry, national, local and global agencies to                                              
ensure its products are produced and marketed in a manner to provide a safe                                               
and nutritional alternative to mothers milk, if the mother chooses not to                                                 
breast-feed or the child is unable to accept mothers milk.                                                                

Projections and Forward Looking Statements:                                                                               

This statement includes projections of future results and forward-looking                                                 
statements as that term is defined in Section 27A of the Securities Act of                                                
1933 as amended the Securities Act, and Section 21E of the Securities Exchange                                            
Act of 1934 as amended the Exchange Act.  All statements that are included in                                             
this Registration Statement, other than statements of historical fact, are                                                
forward looking statements.  Although Management believes that the expectations                                           
reflected in these forward looking statements are reasonable, it can give no                                              
assurance that such expectations will prove to have been correct.  Important                                              
factors that could cause actual results to differ materially from the                                                     
expectations are disclosed in this Statement, including, without limitation, in                                           
conjunction with those forward looking statements contained in this Statement.                                            

S-8 POS 5th Page of 13 TOC 1st Previous Next ↓Bottom Just 5th
There  are  no family relationships between any of the above persons.                                                     
Legal Proceedings                                                                                                         

     The Company is not currently involved in any legal proceedings.                                                      

Properties.                                                                                                               

      EBAIT maintains its administrative offices at 3960 Howard Hughes Pkwy,                                              
Suite 500, Las Vegas, NV 89109.                                                                                           

S-8 POS 6th Page of 13 TOC 1st Previous Next ↓Bottom Just 6th
                            OFFERING SHAREHOLDERS                                                                         

The  following  table lists the shares of Company common  stock  held  by Randal J. Lanham, Esq., the percentage  held  by
him,  and the shares currently proposed to be reoffered by them pursuant  to                                              
this Prospectus.                                                                                                          
317:                                                                                                                      
                                                  Percent                                                                 
                                                  Before       Percent of                                                 
                     Number of     New Shares    Offering     Total After                                                 
Shareholder          Shares  1      Offered         2         Offering                                                    
                                                                                                                          
Randal J. Lanham, Esq.  0           300,000          0%            1.5%                                                   

       TOTAL                        300,000                                                                               

1   Includes  interest  held in other entities whereby  Shareholder  has  a     
controlling interest.                                                           
2  Rounded to nearest percentage.                                               

PART II   

Item 3. Information with Respect to the Company                                 

This  prospectus is accompanied by the Companys Form 10KSB, and its  latest     
10QSB  Quarterly Reports filed subsequent thereto, for quarter  ending  March   
30,  2001.  These Annual, Quarterly and Current Reports, as well as all other   
reports  filed by the Company pursuant to Sections 13a, 13c, 14 or  15d         
of  the Securities Exchange Act of 1934, are hereby incorporated by reference   
in  this  prospectus and may be obtained upon the oral or written request  of   
any person to the Company at 3960 Howard Hughes Pkwy, Suite 500, Las Vegas,     
NV 89109 telephone number 702 990 3623.                                         

Incorporation of Documents by Reference.                                        

The  registrant  incorporates the following documents by  reference  in  this   
Registration Statement:                                                         

a. The registrants Form 10SB12B filed February 2, 2001                          
b. The registrants Form 10SB12B/A filed 2/6/2001                                
c. The registrants Form 10SB12G/A filed 3/9/2001                                
d. The  registrants Quarterly Report on Form 10-QSB filed 5/3/2001              
e  The  registrants Quarterly Report on Form 10-QSB filed 8/14/2001             
f.The  registrants Current Report on 8 K filed 8/29/2001                        
g.The registrants Current Report on 8 K filed 8/31/2001                         

S-8 POS 7th Page of 13 TOC 1st Previous Next ↓Bottom Just 7th
Item 4. Description of Securities                                               

General                                                                         

Common Stock                                                                    

 The  Companys  Articles  of Incorporation authorizes  the  issuance  of
25,000,000  shares  of common stock, $.001 par value per  share,  of  which     
20,000,000 shares were outstanding as of the date of this filing. Holders  of   
shares of common stock are entitled to one vote for each share on all matters   
to  be  voted  on  by the stockholders and have no cumulative voting  rights.   
Holders of shares of common stock are entitled to share ratably in dividends,   
if  any,  as may be declared, from time to time by the Board of Directors  in   
its  discretion, from funds legally available therefore. In the  event  of  a   
liquidation, dissolution or winding up of the Company, the holders of  shares   
of  common  stock  are entitled to share pro rata all assets remaining  after   
payment  in  full  of  all  liabilities. Holders  of  common  stock  have  no   
preemptive  rights  to  purchase the Companys common  stock.  There  are  no    
conversion  rights or redemption or sinking fund provisions with  respect  to   
the  common stock. All of the outstanding shares of common stock are  validly   
issued, fully paid and non assessable.                                          

Preferred Stock                                                                 

The Company has no plans to issue Preferred Stock.                              

Item 5.  Interests of Named Experts and Counsel                                 

None prior to this Prospectus.                                        

S-8 POS 8th Page of 13 TOC 1st Previous Next ↓Bottom Just 8th
Item 6. Indemnification                                                         

  The  Articles of Incorporation for the Company do contain provisions for
indemnification of the officers and directors.  The State Of Nevada provides as 
follows:                                                                        

     Every person who was or is a party to, or is involved in any such action,
suit or proceeding, whether civil, criminal, administrative or investigative,   
by the reason of the fact that he or she with whom he or she is a legal         
representative, is or was a director of the Corporation, or who is serving at   
the request of the Corporation as a director or officer of another corporation, 
or is a representative in a partnership, joint venture, trust or other          
enterprise, shall be indemnified and held harmless to the fullest extent        
legally permissible under the laws of the State of Nevada from time to time     
against all expenses, liability and loss including attorneys fees, judgments,   
fines, and amounts paid or to be paid in a settlement reasonably incurred or    
suffered by him or her in connection therewith.  Such right of indemnification  
shall be a contract right and which may be enforced in any manner desired by    
such person.  The expenses of officers and directors incurred in defending a    
civil suit or proceeding must be paid by the Corporation as incurred and in     
advance of the final deposition of the action, suit, or proceeding must be paid 
by the Corporation as incurred and in advance of the final disposition of the   
action, suit, or proceeding, under receipt of an undertaking by or on behalf of 
the director or officer to repay the amount if it is ultimately determined by a 
court of competent jurisdiction that he or she is not entitled to be            
indemnified by the Corporation.  Such right of indemnification shall not be     
exclusive of any other right of such directors, officers or representatives may 
have or hereafter acquire, and without limiting the generality of such          
statement, they shall be entitled to their respective rights of indemnification 
under any bylaw, agreement, vote of stockholders, provision of law, or          
otherwise, as well as their rights under this article.                          

   Without limiting the application of the foregoing, the Board of Directors
may adopt By Laws from time to time without respect to indemnification, to      
provide at all times the fullest indemnification permitted by the laws of the   
State of Nevada, and may cause the Corporation to purchase or maintain          
insurance on behalf of any person who is or was a director or officer.          
Item 8. Exhibits.                                                               

3.1  Articles of Incorporation of registrant 1.                                 
3.2  Bylaws 2.                                                                  
5    Opinion of Brian Dvorak, Attorney at law, regarding legality of            
shares being issued 3.                                                

Item 9. Undertakings.                                                           

The undersigned registrant hereby undertakes:                                   

1   To  file, during any period in which offers or sales are being made,  a     
post effective amendment to this registration statement:                        
 i   To include any prospectus required by section 10a3 of the
Securities Act of 1933;                                     
     ii To reflect in the prospectus any facts or events arising after
      the  effective  date  of the registration statement  or  the  most
      recent post-effective amendment thereof which, individually or  in
       the  aggregate,  represent a fundamental change in the  information
set forth in the registration statement;                    
     iii      To include any material information with respect to  the
       plan  of  distribution not previously disclosed in the registration
       statement  or  any  material  change to  such  information  in  the
     registration statement, including but not limited to any addition
or election of a managing underwriter.                      

2  That,  for the purpose of determining any liability under the Securities     
Act  of 1933, each such post-effective amendment shall be deemed to be a  new   
registration  statement relating to the securities offered therein,  and  the   
offering  of such securities offered at that time shall be deemed to  be  the   
initial bona fide offering thereof.                                             

3 To remove from registration by means of a post-effective amendment any of     
the securities being registered which remain unsold at the termination of the   
offering.                                                                       

S-8 POS 9th Page of 13 TOC 1st Previous Next ↓Bottom Just 9th
   The  undersigned  registrant hereby undertakes that,  for  purposes  of
determining  any liability under the Securities Act of 1933, each  filing  of   
the  Companys  annual  report pursuant to Section  13a  or  15d  of  the        
Securities  Exchange Act of 1934 and, where applicable, each  filing  of  an    
employee  benefit  plans  annual report pursuant to  Section  15d  of  the      
Securities  Exchange Act of 1934 that is incorporated by  reference  in  the    
registration  statement  shall be deemed to be a new  registration  statement   
referring  to  the  securities offered therein,  and  the  offering  of  such   
securities at that time shall be deemed to be the initial bona fide  offering   
thereof.                                                                        

   Insofar as indemnification for liabilities arising under the Securities
Act  of  1933 may be permitted to directors, officers and controlling persons   
of  the  Company  pursuant  to the foregoing provisions,  or  otherwise,  the   
Company  has been advised that in the opinion of the Securities and  Exchange   
Commission such indemnification is against public policy as expressed in  the   
Act  and  is,  therefore,  unenforceable. In  the  event  that  a  claim  for   
indemnification  against  such liabilities other than  the  payment  by  the    
Company  in  the  successful defense of any action, suit  or  proceeding  is    
asserted  by such director, officer or controlling person in connection  with   
the  securities being registered, the Company will, unless in the opinion  of   
its counsel that matter has been settled by controlling precedent, submit  to   
a court of appropriate jurisdiction the question whether such indemnification   
by  it  is against public policy as expressed in the Act and will be governed   
by the final adjudication of such issue.                                        

S-8 POS 10th Page of 13 TOC 1st Previous Next ↓Bottom Just 10th
SIGNATURES    

   Pursuant  to  the  requirements of the  Securities  Act  of  1933,  the
registrant certifies that it has reasonable grounds to believe that it  meets   
all  of  the  requirements for filing on Form S8 and has  duly  caused  this    
registration  statement  to  be  signed on its  behalf  by  the  undersigned,   
thereunto  duly  authorized, in the City of Las Vegas, State of  Nevada,  on    
this 8th day of October, 2001.                                                  

EBAIT, INC.                                                                     

By :s Darrel Holmes                                                             
Darrel Holmes, President                                            

Pursuant to the requirements of the Securities Act of 1933, this registration   
statement  has  been  signed  by  the following  persons  in  the  capacities   
indicated on October 8, 2001.                                                   

Signature              Title                                   Date             

s   Darrel Holmes      President                       October 8, 2001          
Darrel Holmes                                                           

s   Rendal Williams    Director                        October 8, 2001          
Rendal Williams                                                         

S-8 POS 11th Page of 13 TOC 1st Previous Next ↓Bottom Just 11th
EXHIBIT 5   
Opinion and Consent of    
Brian Dvorak      

S-8 POS 12th Page of 13 TOC 1st Previous Next ↓Bottom Just 12th
ATTORNEY AT LAW                                                                 
                              Telephone 702 794 4992
                              Facsimile 702 932 5214
BRIAN DVORAK                                                                    

3360 W. Sahara Suite 230, Las Vegas, NV 89102                                   
               October 9, 2001

Mr. Darrel Holmes                                                               
President                                                                       
EBAIT, INC.                                                                     
3960 Howard Hughes Pkwy Suite 500                                               
Las Vegas, NV 89109                                                             

RE: REGISTRATION STATEMENT ON FORM S8                                 

Dear Mr. Holmes:                                                                

You have requested our opinion as to the legality of the registration by you,   
EBAIT, INC. (the Corporation) of up to 300,000 shares of Common  Stock          
the shares pursuant to a Registration Statement, dated August 3, 2001, on       
Form S8 the Registration Statement to be filed on August 7, 2001:               

As your counsel we have reviewed and examined:                                  

1.   The  Articles  of  Incorporation of the  Corporation,  as  amended  the    
Articles;                                                             

2.   The  Bylaws  of  the Corporation, as certified by the Secretary  of  the   
Corporation;                                                          

3.   The Resolutions of the corporation authorizing the registration;           

4.   The minute book of the Corporation;                                        

5.  The Consultant and Employee Stock Compensation Plan; and                    

6.  Such  other  matters as we have deemed relevant in  order  to  form  our    
opinion.                                                              

S-8 POS Last Page of 13 TOC 1st Previous Next ↓Bottom Just 13th
In giving our opinion, we have assumed without investigation the authenticity   
of  any document or instrument submitted to us as an original, the conformity   
to  the original of any document or instrument submitted to us as a copy, and   
the genuineness of all signatures on such originals or copies.                  

Based  upon the foregoing, and subject to the qualifications set forth below,   
we are of the opinion that the Shares, if issued and sold as described in the   
Registration  Statement (provided that at least par value  is  paid  for  the   
shares):  i will have been duly authorized, legally issued, fully paid  and     
nonassessable, ii when issued will be a valid and binding obligation of the     
corporation, and  iii do not require a permit from any governmental agency.     
Our  opinion  is  subject to the qualification that no opinion  is  expressed   
herein as to the application of the state securities or Blue Sky laws.          

This  Opinion  is  furnished by us as counsel to you and is solely  for  your   
benefit.  Neither  this  opinion nor copies hereof may  be  relied  upon  by,   
delivered  to,  or quoted in whole or in part to any governmental  agency  or   
other person without our prior written consent.                                 

Notwithstanding the above, we consent to the use of our opinion in regards to   
the Request to Transfer Agent for transfer of the above referred to shares.     

                 Yours Very Truly,

              s Brian Dvorak

            Brian Dvorak

S-8 POS	1st Page of 13	TOC	↑Top	Previous	Next	↓Bottom	Just 1st

S-8 POS	2nd Page of 13	TOC	1st	Previous	Next	↓Bottom	Just 2nd

S-8 POS	3rd Page of 13	TOC	1st	Previous	Next	↓Bottom	Just 3rd

S-8 POS	4th Page of 13	TOC	1st	Previous	Next	↓Bottom	Just 4th

S-8 POS	5th Page of 13	TOC	1st	Previous	Next	↓Bottom	Just 5th

S-8 POS	6th Page of 13	TOC	1st	Previous	Next	↓Bottom	Just 6th

S-8 POS	7th Page of 13	TOC	1st	Previous	Next	↓Bottom	Just 7th

S-8 POS	8th Page of 13	TOC	1st	Previous	Next	↓Bottom	Just 8th

S-8 POS	9th Page of 13	TOC	1st	Previous	Next	↓Bottom	Just 9th

S-8 POS	10th Page of 13	TOC	1st	Previous	Next	↓Bottom	Just 10th

S-8 POS	11th Page of 13	TOC	1st	Previous	Next	↓Bottom	Just 11th

S-8 POS	12th Page of 13	TOC	1st	Previous	Next	↓Bottom	Just 12th

S-8 POS	Last Page of 13	TOC	1st	Previous	Next	↓Bottom	Just 13th

Dates Referenced Herein and Documents Incorporated by Reference

		Referenced-On Page
This ‘S-8 POS’ Filing	Date	First	Last	Other Filings

Filed on / Effective on:	10/29/01			S-8
	10/9/01	1	12
	10/8/01	10
	8/7/01	12
	8/3/01	12
	3/30/01	6
	2/2/01	6		10SB12B, 10SB12G
				List all Filings

↑Top

Filing Submission 0001104194-01-500019 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Noble Consolidated Industries Corp – ‘S-8 POS’ on 10/29/01

On: Monday, 10/29/01 · Effective: 10/29/01 · Accession #: 1104194-1-500019 · File #: 333-72382

Post-Effective Amendment to an S-8 — Form S-8Filing Table of Contents

Document Table of Contents

Dates Referenced Herein and Documents Incorporated by Reference

Post-Effective Amendment to an S-8 — Form S-8
Filing Table of Contents